Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AHTC Corp (AHTC)-formerly Advanced Health (ADVH) -- Ignore unavailable to you. Want to Upgrade?

To: Tom D who wrote (85)	3/23/1998 11:29:00 AM
From: Dennis Giasi	Read Replies (1) \| Respond to of 371

Sorry to hear of your losses. I too have made a few bad calls on stocks but who in the market hasn't? ADVH has eaten up all my profits for this year, so far. As far as ADVH goes, do you know how strong this company is? Whether or not there is a problem, how do you see the future of ADVH. I am not looking for advice. Just another's opinion. Reply appreciated.

To: Tom D who wrote (85)	3/28/1998 1:03:00 AM
From: Bob Barels	Read Replies (1) \| Respond to of 371

Thanks for your post at the DEPO site. It looks like I am not the only one complaining. However, I might be the only one who followed you in both ABTI and DEPO. To be honest I bought ABTI because I had direct information (apparently false; read my ABTI posts the last few days )but your analysis back in July made me feel a sure winner. After the failure of Betafectin, I followed you (you suggested everyone) in the DEPO site. Another sure winner but at the end it was a disaster. So you tell me what am I supposed to think? Incidentally, DEPO is presenting next week in The Netherlands (Controlled Release Society) results from their failure. I am going to have a word with them, since I am also presenting in that conference. The conference program was out before their FDA results. I any case, I was wiped out mainly from ABTI but I learned a lesson. It looks like that 9 out of 10 biotech stocks do not get approval (CTIC is the latest example) thus, we have better chances shorting all those who are expecting FDA results (visit the ALLP thread). My only hopes are on ETHCY (controlled release is my field; visit their thread if you want). By the way I don't intend to short ADVH. I prefer to short companies that do not make money and their stock price is based on potential FDA approval. No hard feelings for ABTI and DEPO. My ABTI post was written before this one. regards